Literature DB >> 16000491

Evaluation of the COBAS TaqMan 48 real-time PCR system for quantitation of hepatitis B virus DNA.

Rafael M Gordillo1, Juan Gutiérrez, Manuel Casal.   

Abstract

The purpose of this study is to evaluate the usefulness of the new real-time PCR COBAS TaqMan 48 analyzer, comparing it to the existing COBAS AMPLICOR HBV MONITOR based on conventional PCR technology. The study used 104 samples from different patients. No differences were found in the sensitivity of the tests. There was an excellent correlation between the sample with a viral load within the dynamic range of the two tests (r = 0.938). The COBAS TaqMan test has a wider linear range, and this fact enables quantifying of the viral load without diluting the sample.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16000491      PMCID： PMC1169135          DOI： 10.1128/JCM.43.7.3504-3507.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  Management of hepatitis B: 2000--summary of a workshop.

Authors:  A S Lok; E J Heathcote; J H Hoofnagle
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

Review 2.  [Real-time PCR].

Authors:  Josep Costa
Journal:  Enferm Infecc Microbiol Clin       Date:  2004-05       Impact factor: 1.731

Review 3.  Hepatitis B virus infection--natural history and clinical consequences.

Authors:  Don Ganem; Alfred M Prince
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

4.  Comparative evaluation of semiautomated COBAS AMPLICOR hepatitis B virus (HBV) monitor test and manual microwell plate-based AMPLICOR HBV MONITOR test.

Authors:  I J Marin; M Poljak; K Seme; J Meglic-Volkar; M Maticic; G Lesnicar; V Brinovec
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Assessment of the COBAS Amplicor HBV Monitor Test for quantitation of serum hepatitis B virus DNA levels.

Authors:  Vincent A Lopez; Eric J Bourne; Michael W Lutz; Lynn D Condreay
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test.

Authors:  U Noborg; A Gusdal; E K Pisa; A Hedrum; M Lindh
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

7.  Semiautomated quantification of hepatitis B virus DNA in a routine diagnostic laboratory.

Authors:  H H Kessler; E Stelzl; E Daghofer; B I Santner; E Marth; H Lackner; R E Stauber
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

8.  Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays.

Authors:  S D Pas; E Fries; R A De Man; A D Osterhaus; H G Niesters
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

9.  Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard.

Authors:  J Weiss; H Wu; B Farrenkopf; T Schultz; G Song; S Shah; J Siegel
Journal:  J Clin Virol       Date:  2004-05       Impact factor: 3.168

10.  Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay.

Authors:  G Gerken; J Gomes; P Lampertico; M Colombo; T Rothaar; M Trippler; G Colucci
Journal:  J Virol Methods       Date:  1998-10       Impact factor: 2.014
View more
  12 in total

1.  Current status of antiviral therapy for hepatitis B.

Authors:  Daryl T-Y Lau; Wissam Bleibel
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

2.  COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma.

Authors:  Tiziano Allice; Francesco Cerutti; Fabrizia Pittaluga; Silvia Varetto; Silvia Gabella; Alfredo Marzano; Alessandro Franchello; Giuseppe Colucci; Valeria Ghisetti
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

3.  Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study.

Authors:  Syria Laperche; Vincent Thibault; Françoise Bouchardeau; Sophie Alain; Sandrine Castelain; Michelle Gassin; Marie Gueudin; Philippe Halfon; Sylvie Larrat; Françoise Lunel; Michèle Martinot-Peignoux; Bernard Mercier; Jean-Michel Pawlotsky; Bruno Pozzetto; Anne-Marie Roque-Afonso; Françoise Roudot-Thoraval; Karine Sauné; Jean-Jacques Lefrère
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

4.  A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA.

Authors:  Ying Liu; Munira Hussain; Stephen Wong; Scott K Fung; Hyung Joon Yim; Anna S F Lok
Journal:  J Clin Microbiol       Date:  2006-12-20       Impact factor: 5.948

5.  Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.

Authors:  Christophe Ronsin; Anne Pillet; Corinne Bali; Gérard-Antoine Denoyel
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  Comparison of real-time polymerase chain reaction with the COBAS Amplicor test for quantitation of hepatitis B virus DNA in serum samples.

Authors:  Ming Shi; Yong Zhang; Ying-Hua Zhu; Jing Zhang; Wei-Jia Xu
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

7.  Evaluation of the Abbott RealTime HBV DNA assay and comparison to the Cobas AmpliPrep/Cobas TaqMan 48 assay in monitoring patients with chronic cases of hepatitis B.

Authors:  Marco Ciotti; Fabbio Marcuccilli; Tania Guenci; Maria Grazia Prignano; Carlo Federico Perno
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

Review 8.  Molecular testing in the diagnosis and management of chronic hepatitis B.

Authors:  Alexandra Valsamakis
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 9.  Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.

Authors:  Jean-Michel Pawlotsky; Geoffrey Dusheiko; Angelos Hatzakis; Daryl Lau; George Lau; T Jake Liang; Stephen Locarnini; Paul Martin; Douglas D Richman; Fabien Zoulim
Journal:  Gastroenterology       Date:  2007-11-28       Impact factor: 22.682

10.  Anti-hepatitis B virus X protein in sera is one of the markers of development of liver cirrhosis and liver cancer mediated by HBV.

Authors:  Hang Zhang; Lian-Ying Wu; Shuai Zhang; Li-Yan Qiu; Nan Li; Xuan Zhang; Xue-Zhi Zhang; Chang-Liang Shan; Li-Hong Ye; Xiao-Dong Zhang
Journal:  J Biomed Biotechnol       Date:  2009-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.